Prescription drug · ANDA
Metoprolol Tartrate (metoroprolol tartrate) NDC 71872-7244
Metoprolol tartrate 5 mg/5mL · Injection, Solution · Intravenous · Medical Purchasing Solutions, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71872-7244-1 | 71872724401 | 1 VIAL in 1 BAG (71872-7244-1) / 5 mL in 1 VIALMarketed from Mar 24, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol Tartrate
- Generic name (nonproprietary)
- metoroprolol tartrate
- Active ingredients
- Metoprolol tartrate — 5 mg/5mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077761
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 71872-7244_fa5960de-b894-25ae-e053-6394a90ac17fSPL ID fa5960de-b894-25ae-e053-6394a90ac17fSPL set ID bfc8834e-1df8-170b-e053-2995a90a28f1RxCUI 866508UNII W5S57Y3A5L
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471872724401followed by a unit qualifier and the quantityPackage 71872-7244-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol Tartrate Injection, USP is indicated in the treatment of definite or suspected acute myocardial infarction in hemodynamically stable patients to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy. Metoprolol Tartrate Injection is a beta-adrenergic receptor inhibitor indicated for the treatment of definite or suspected acute myocardial infarction in hemodynamically stable patients to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy ( 1 ).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077761
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol Tartrate | Metoprolol tartrate 5 mg/5mL | Injection, SolutionIntravenous | Medical Purchasing Solutions, LLC | 71872-7225 |
| Metoprolol Tartrate | Metoprolol tartrate 5 mg/5mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9873 |
| Metoprolol Tartratemetoroprolol tartrate | Metoprolol tartrate 5 mg/5mL | Injection, SolutionIntravenous | Civica, Inc. | 72572-420 |
| Metoprolol Tartratemetoroprolol tartrate | Metoprolol tartrate 5 mg/5mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9660 |